Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D09HAL
|
|||
| Former ID |
DIB005734
|
|||
| Drug Name |
JTT-651
|
|||
| Synonyms |
Glycogen phosphorylase inhibitor (oral, diabetes) Japan Tobacco
Click to Show/Hide
|
|||
| Indication | Type-2 diabetes [ICD-11: 5A11; ICD-9: 250] | Discontinued in Phase 1 | [1] | |
| Company |
Japan Tobacco Inc
|
|||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Glycogen phosphorylase muscle form (GP) | Target Info | Inhibitor | [2] |
| BioCyc | Glycogenolysis | |||
| KEGG Pathway | Starch and sucrose metabolism | |||
| Metabolic pathways | ||||
| Insulin signaling pathway | ||||
| Glucagon signaling pathway | ||||
| Panther Pathway | Heterotrimeric G-protein signaling pathway-Gi alpha and Gs alpha mediated pathway | |||
| WikiPathways | Glycogen Metabolism | |||
| Metabolism of carbohydrates | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800026877) | |||
| REF 2 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800026877) | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.